Abstract
Pediatric pulmonary arterial hypertension (PAH) presents certain specific features. In this specific age group, experimental models to study the pathophysiology of PAH are lacking. To characterize hemodynamic, morphometric, and histological progression as well as the expression of neurohumoral factors and regulators of cardiac transcription in an infantile model of PAH induced by monocrotaline (MCT), eight-day-old Wistar rats were randomly injected with MCT (30 mg/kg, sc, n = 95) or equal volume of saline solution (n = 92). Animals were instrumented for biventricular hemodynamic recording 7, 14, and 21 days after MCT, whereas samples were collected at 1, 3, 7, 14, and 21 days after MCT. Different time point postinjections were defined for further analysis. Hearts and lungs were collected for morphometric characterization, assessment of right- and left-ventricle (RV and LV) cardiomyocyte diameter and collagen type-I and type-III ratio, RV collagen volume fraction, and pulmonary vessels wall thickness. mRNA quantification was undertaken for brain natriuretic peptide (BNP), endothelin-1 (ET-1), and for cardiac transcription regulators (HOP and Islet1). Animals treated with MCT at the 8th day of life presented RV hypertrophy since day 14 after MCT injection. There were no differences on the RV collagen volume fraction or collagen type-I and type-III ratio. Pulmonary vascular remodelling and PAH were present on day 21, which were accompanied by an increased expression of BNP, ET-1, HOP, and Islet1. The infantile model of MCT-induced PAH can be useful for the study of its pathophysiology and to test new therapeutic targets in pediatric age group.
Similar content being viewed by others
References
Adachi S, Ito H, Ohta Y, Tanaka M, Ishiyama S, Nagata M, Toyozaki T, Hirata Y, Marumo F, Hiroe M (1995) Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding. Am J Physiol 268:H162–H169
Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92:1079–1088
Bourdillon PD, Oakley CM (1976) Regression of primary pulmonary hypertension. Br Heart J 38:264–270
Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5:877–889
Campian ME, Verberne HJ, Hardziyenka M, de Bruin K, Selwaness M, van den Hoff MJ, Ruijter JM, van Eck-Smit BL, de Bakker JM, Tan HL (2009) Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats. J Nucl Med 50:1371–1377
Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R Jr, Lourenco AP, Melo-Rocha G, Vasques-Novoa F, Gillebert TC, Leite-Moreira AF (2009) Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol 104:535–545
Epstein JA, Parmacek MS (2005) Recent advances in cardiac development with therapeutic implications for adult cardiovascular disease. Circulation 112:592–597
Falcao-Pires I, Goncalves N, Henriques-Coelho T, Moreira-Goncalves D, Roncon-Albuquerque R Jr, Leite-Moreira AF (2009) Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 296:H2007–H2014
Frank L, Bucher JR, Roberts RJ (1978) Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45:699–704
Fujii A, Rabinovitch M, Matthews EC (1981) A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J 46:574–577
Garciarena CD, Pinilla OA, Nolly MB, Laguens RP, Escudero EM, Cingolani HE, Ennis IL (2009) Endurance training in the spontaneously hypertensive rat: conversion of pathological into physiological cardiac hypertrophy. Hypertension 53:708–714
Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr, Baptista MJ, Lourenco AP, Oliveira SM, Brandao-Nogueira A, Teles A, Fortunato JM, Leite-Moreira AF (2004) Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 287:H2885–H2890
Ismat FA, Zhang M, Kook H, Huang B, Zhou R, Ferrari VA, Epstein JA, Patel VV (2005) Homeobox protein Hop functions in the adult cardiac conduction system. Circ Res 96:898–903
Jasmin JF, Lucas M, Cernacek P, Dupuis J (2001) Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension. Circulation 103:314–318
Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455
Kook H, Lepore JJ, Gitler AD, Lu MM, Yung WWM, Mackay J, Zhou R, Ferrari V, Gruber P, Epstein JA (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112:863–871
Lalich JJ, Merkow L (1961) Pulmonary arteritis produced in rat by feeding Crotalaria spectabilis. Lab Invest 10:744–750
Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR (2005) Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647–653
Loscalzo J (1992) Endothelial dysfunction in pulmonary hypertension. N Engl J Med 327:117–119
Mattocks AR (1968) Toxicity of pyrrolizidine alkaloids. Nature 217:723–728
Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K (1993) Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73:887–897
Piepoli MF, Capucci A (2009) Cardiac regeneration by progenitor cells: what is it known as and what is it still to be known as? Cardiovasc Hematol Agents Med Chem 7:127–136
Rabinovitch M, Gamble WJ, Miettinen OS, Reid L (1981) Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 240:H62–H72
Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L (1984) Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 69:655–667
Reffelmann T, Kloner RA (2009) Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med 4:709–719
Reid MJ, Lame MW, Morin D, Wilson DW, Segall HJ (1998) Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes. J Biochem Mol Toxicol 12:157–166
Rosenzweig EB, Barst RJ (2008) Pulmonary arterial hypertension in children: a medical update. Curr Opin Pediatr 20:288–293
Rosenzweig EB, Widlitz AC, Barst RJ (2004) Pulmonary arterial hypertension in children. Pediatr Pulmonol 38:2–22
Stamm C, Choi YH, Nasseri B, Hetzer R (2009) A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart. Ther Adv Cardiovasc Dis 3:215–229
Su X, Brower G, Janicki JS, Chen YF, Oparil S, Dell’Italia LJ (1999) Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol 31:1927–1936
Tatebe S, Miyamura H, Sugawara M, Watanabe H, Eguchi S (1996) Induction of right ventricular hypertrophy in neonatal guinea pigs by monocrotaline. Jpn Circ J 60:604–608
Todd L, Mullen M, Olley PM, Rabinovitch M (1985) Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res 19:731–737
Ueno M, Miyauchi T, Sakai S, Kobayashi T, Goto K, Yamaguchi I (1999) Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors. Am J Physiol 277:R1321–R1330
Zuo XR, Wang Q, Cao Q, Yu YZ, Wang H, Bi LQ, Xie WP, Wang H (2012) Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension. PLoS One 7:e44485
Acknowledgments
The authors thank Antónia Teles, Marta Oliveira, and Rosa Gonçalves for their invaluable technical assistance in this study.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dias-Neto, M., Luísa-Neves, A., Pinho, S. et al. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline. Pediatr Cardiol 36, 1000–1013 (2015). https://doi.org/10.1007/s00246-015-1111-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-015-1111-y